Carla
Carla Baerg, Bellingham, WA US
Patent application number | Description | Published |
---|---|---|
20090081625 | MATHEMATICS TEACHING AID - An apparatus and method for teaching involving teaching manipulatives. The teaching manipulative comprises a longitudinal rod having a plurality of multi-faced objects disposed upon its surface which are capable of substantially sliding along the length of the rod and have a unique object identifier disposed on each face. On either end of the rod is a stop member having a row identifier substantially in alignment with the unique identifiers on the faces of the multi-faced object. | 03-26-2009 |
Carla Bandeira, Voorhees, NJ US
Patent application number | Description | Published |
---|---|---|
20090076509 | Dynamic cervical plate - A dynamic subsidence plate is described having a first plate member and a second plate member in sliding engagement that may infinitely subside between a first and second assembled position. The plate includes a lock assembly associated with the first and second plate members. The lock assembly includes a ramp portion, an interference portion, and a bearing member situated between the ramp portion and the interference portion. The lock assembly of the plate is configured to allow movement of the first member with respect to the second member in a first direction in an infinite number of positions between a first assembled position and a second assembled position. Further, the lock assembly alternatively prevents movement of the first member with respect to the second member in an opposite second direction between the first and second assembled positions. | 03-19-2009 |
20130150897 | DYNAMIC CERVICAL PLATE - A dynamic subsidence plate is described having a first plate member and a second plate member in sliding engagement that may infinitely subside between a first and second assembled position. The plate includes a lock assembly associated with the first and second plate members. The lock assembly includes a ramp portion, an interference portion, and a bearing member situated between the ramp portion and the interference portion. The lock assembly of the plate is configured to allow movement of the first member with respect to the second member in a first direction in an infinite number of positions between a first assembled position and a second assembled position. Further, the lock assembly alternatively prevents movement of the first member with respect to the second member in an opposite second direction between the first and second assembled positions. | 06-13-2013 |
20160106484 | DYNAMIC CERVICAL PLATE - A dynamic subsidence plate is described having a first plate member and a second plate member in sliding engagement that may infinitely subside between a first and second assembled position. The plate includes a lock assembly associated with the first and second plate members. The lock assembly includes a ramp portion, an interference portion, and a bearing member situated between the ramp portion and the interference portion. The lock assembly of the plate is configured to allow movement of the first member with respect to the second member in a first direction in an infinite number of positions between a first assembled position and a second assembled position. Further, the lock assembly alternatively prevents movement of the first member with respect to the second member in an opposite second direction between the first and second assembled positions. | 04-21-2016 |
Carla Baratta, Legnano (verona) IT
Patent application number | Description | Published |
---|---|---|
20110014092 | GRADUAL-RELEASE DOSING DEVICE FOR SUBSTANCES IN DOMESTIC-USE APPARATUSES, IN THE PRESENCE OF WATER - A gradual-release dosing device ( | 01-20-2011 |
Carla Barosso, Kunda Park AU
Patent application number | Description | Published |
---|---|---|
20120227572 | KEYBOARD MUSICAL INSTRUMENT LEARNING AID - A keyboard musical instrument learning aid having a plurality of keys including: sensing means operatively associated with the keyboard for sensing the presence of an object at a spaced disposition with respect to the keys of the keyboard; positioning means operatively associated with the sensing means for positioning the sensing means such that the spaced disposition is within a predetermined space with respect to the keys; and reporting means operatively associated with the sensing means and operable to report when an object is sensed to be present at the spaced disposition. | 09-13-2012 |
Carla Boccaccio, Torino IT
Patent application number | Description | Published |
---|---|---|
20120237524 | MET INHIBITORS FOR ENHANCING RADIOTHERAPY EFFICACY - Met inhibitor and/or nucleotide sequence encoding a Met inhibitor for use in the treatment of patients suffering from a cancer for reducing and/or abrogating patients' resistance to radiotherapy, wherein the Met inhibitor is selected among: i) an anti-Met monoclonal antibody, ii) a genetically engineered antibody containing the complementarity determining regions (CDRs) of the anti-Met monoclonal antibody, and iii) a fragment of (i) or (ii) containing the complementarity determining regions (CDRs) of the anti-Met monoclonal antibody, or combinations thereof. | 09-20-2012 |
Carla Byloos, Dresden DE
Patent application number | Description | Published |
---|---|---|
20100266939 | Lithographic Mask and Method of Forming a Lithographic Mask - A lithographic mask comprises a first layer including grooves, a second layer including regions, sections and a groove-like structure that encloses the sections. The first and second layers are formed so as to reduce electrical potential differences within the second layer. A method of forming a lithographic mask includes forming first and second layers to dispose the second layer over the first layer, patterning the second layer to comprise sections, a region, and a groove-like structure enclosing the sections, and forming grooves in the first layer at portions not covered by the second layer. The first and second layers are formed to reduce potential differences within the second layers during the step of forming the grooves in the first layer. | 10-21-2010 |
Carla Caramella, Bologna IT
Patent application number | Description | Published |
---|---|---|
20090081133 | Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations - Mucoadhesive and controlled release formulations consisting of aqueous solutions containing 0.05% to 5% by weight of a natural purified polymer having xyloglucan structure and 10% to 70% by weight of glycerol. These formulations are suitable for the application on human mucous membranes, such as nasal, oral and vaginal mucous membranes, as moisturizing and softening agents or as pharmaceutical release system. Further objects of the invention are pharmaceutical formulations and medical devices suitable for the application to human mucous membranes, containing the mucoadhesive and controlled release formulations together with active ingredients and excipients. | 03-26-2009 |
20120088726 | MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONS USEFUL IN MEDICAL DEVICES AND IN PHARMACEUTICAL FROMULATIONS - Object of the invention are mucoadhesive and controlled release formulations consisting of aqueous solutions containing 0.05% to 5% by weight of a natural purified polymer having xyloglucan structure and 10% to 70% by weight of glycerol. These formulations are suitable for the application on human mucous membranes, such as nasal, oral and vaginal mucous membranes, as moisturizing and softening agents or as pharmaceutical release system. Further objects of the invention are pharmaceutical formulations and medical devices suitable for the application to human mucous membranes, containing the mucoadhesive and controlled release formulations together with active ingredients and excipients. | 04-12-2012 |
20130183325 | MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONS USEFUL IN MEDICAL DEVICES AND IN PHARMACEUTICAL FORMULATIONS - Object of the invention are mucoadhesive and controlled release formulations consisting of aqueous solutions containing 0.05% to 5% by weight of a natural purified polymer having xyloglucan structure and 10% to 70% by weight of glycerol. These formulations are suitable for the application on human mucous membranes, such as nasal, oral and vaginal mucous membranes, as moisturizing and softening agents or as pharmaceutical release system. Further objects of the invention are pharmaceutical formulations and medical devices suitable for the application to human mucous membranes, containing the mucoadhesive and controlled release formulations together with active ingredients and excipients. | 07-18-2013 |
Carla Cerami Hand, Chapel Hill, NC US
Patent application number | Description | Published |
---|---|---|
20090004202 | METHODS FOR TREATMENT OF NEURODEGENERATIVE CONDITIONS BY PERIPHERALLY ADMINISTERED ERYTHROPOIETIN - Methods and compositions are provided for protecting or enhancing excitable tissue function in mammals by systemic administration of an erythropoietin receptor activity modulator, such as erythropoietin, which signals via an EPO-activated receptor to modulate the function of excitable tissue. Excitable tissues include central neuronal tissues, such as the brain, peripheral neuronal tissues, retina, and heart tissue. Protection of excitable tissues provides treatment of hypoxia, seizure disorders, neurodegenerative diseases, hypoglycemia, and neurotoxin poisoning. Enhancement of function is useful in learning and memory. The invention is also directed to compositions and methods for facilitating the transport of molecules across endothelial cell tight junction barriers, such as the blood-brain barrier, by association of molecules with an erythropoietin receptor activity modulator, such as an erythropoietin. | 01-01-2009 |
Carla Danussi, Udine IT
Patent application number | Description | Published |
---|---|---|
20090202580 | METHOD FOR THE PREPARATION OF SPECIFIC ANTIBODIES AGAINST SACCHARIDIC ANTIGENS - The present invention relates to new compounds useful for the stimulation of the production of antibodies. Said compounds comprises a saccharidic tumor antigen and a polymeric scaffold. The present invention also encompasses conjugated compounds useful in ELISA assay for the selection of antibodies against saccharidic antigens. | 08-13-2009 |
Carla Degenhardt-Langelaan, Delft NL
Patent application number | Description | Published |
---|---|---|
20120018628 | MATRIX FOR REAL-TIME AEROSOL MASS SPECTROMETRY OF ATMOSPHERIC AEROSOLS AND REAL-TIME AEROSOL MALDI MS METHOD - Matrix for real-time aerosol mass spectrometry of atmospheric aerosols and real-time aerosol MALDI MS method Abstract The invention is directed to a matrix material for MALDI mass spectrometry, to a matrix composition for MALDI mass spectrometry, in particular for aerosol MALDI mass spectrometry, to a MALDI mass spectrometry method, in particular an aerosol MALDI mass spectrometry method, to the use of a specific compound as a MALDI matrix material, and to the use of a MALDI matrix composition in a gas phase coating method. The matrix material of the invention comprises a 2-mercapto-4,5-dialkylthiazole according to formula (I), wherein X is chosen from S, O or N, and wherein R | 01-26-2012 |
Carla De Giovanni, Bologna IT
Patent application number | Description | Published |
---|---|---|
20140213583 | PI3K Inhibitor for Use in the Treatment of Bone Cancer or for Preventing Metastatic Dissemination Primary Cancer Cells into the Bone - Provided herein are methods for the treatment of bone cancer and prevention of the metastatic spread of cancer. | 07-31-2014 |
Carla Degrouchy, Bowie, MD US
Patent application number | Description | Published |
---|---|---|
20150121662 | HANDS FREE BEVERAGE AND KEY RING HOLDER - A container engagement retainment band for resiliently securing selectively about the surface of a container with a universal clip extending therefrom. The attachment clip provides dual selective access portions for band engagement by deformable adjacent ring portions allowing for clip placement and positioning about the band and selective attachment portion access via displacement of aligned portion thereon dependent on user's need or preference use accessibility. | 05-07-2015 |
Carla Delannoy, Edina, MN US
Patent application number | Description | Published |
---|---|---|
20150237878 | MULTI-PACKET SYSTEM FOR THICKENED BEVERAGES - Thickened milk and fruit containing beverages and components thereof are provided. In a general embodiment, the present disclosure provides a shelf-stable beverage component product including a dry components packet and a wet components packet. The dry components packet includes milk powder. The wet components packet includes a fruit component and a carrageenan component. The wet components packet is at least in a partially liquid state. The dry components packet and the wet components packet are combined together in a liquid carrier to provide a thickened beverage. | 08-27-2015 |
Carla Delannoy, Chexbres CH
Patent application number | Description | Published |
---|---|---|
20100297329 | SPREADABLE DAIRY PRODUCT - The invention concerns a shelf stable spread that includes sweetened condensed milk of fat content 2 to 25% by weight and water content 15 to 35% by weight and at least one organoleptic modifying food substance added at a ratio ranging from 2% to 30% by weight and preferably 5% to 15% by weight wherein the spread is substantially free of emulsifiers and thickeners, is not caramelised and is thickened by shear so that it has a firmness corresponding to a maximum compression force of at least 20 g measured at 25° C. by a Texture Analyser equipped with a 5 kg load cell and a 20 mm diameter cylinder probe with a penetration into the sample at a constant speed 1 mm/s during 10 s. | 11-25-2010 |
20140037821 | SPREADABLE DAIRY PRODUCT - The invention concerns a shelf stable spread that includes sweetened condensed milk of fat content 2 to 25% by weight and water content 15 to 35% by weight and at least one organoleptic modifying food substance added at a ratio ranging from 2% to 30% by weight and preferably 5% to 15% by weight wherein the spread is substantially free of emulsifiers and thickeners, is not caramelised and is thickened by shear so that it has a firmness corresponding to a maximum compression force of at least 20 g measured at 25° C. by a Texture Analyser equipped with a 5 kg load cell and a 20 mm diameter cylinder probe with a penetration into the sample at a constant speed 1 mm/s during 10 s. | 02-06-2014 |
Carla Denotti, Siracusa IT
Patent application number | Description | Published |
---|---|---|
20160130154 | PROCESS FOR THE EXTRACTION, FROM BAUXITE, FROM RED MUD RESULTING FROM THE PROCESSING OF BAUXITE, AND FROM CHEMICALLY SIMILAR MATERIALS, OF PRODUCTS OF INDUSTRIAL INTEREST, SEPARATED FROM EACH OTHER - The subject of the invention is a process for the extraction, from bauxite, from red mud resulting from the processing of bauxite, and from chemically similar materials, of products of industrial interest, like sodium, iron, gallium, aluminum, titanium and silicon, separated from each other in chloride form. | 05-12-2016 |
Carla De Young, Joliet, IL US
Patent application number | Description | Published |
---|---|---|
20090139776 | Scale - The scale may include a base supportable on a surface, a measuring mechanism supported by the base and operable to measure a characteristic of an object, the measuring mechanism including a measuring platform on which the object is supportable, and an indicator supported by the housing, the indicator being operable to provide feedback to a user relating to a measured characteristic of the object. In some aspects, the scale may include a housing supported by the base, the housing cooperating with the base to cover at least a portion of the measuring mechanism, and a connecting assembly operable to removably connect the housing to the base. In some aspects, the scale may include a resistance device coupled to at least one of the indicator and the measuring mechanism and operable to resist oscillation of the indicator at least one of during a measurement and after a measurement. In some aspects, the scale may include a cylinder supported by the housing, and a piston connected to the platform for movement with the platform, the piston engaging the cylinder to provide a piston and cylinder assembly, the assembly being operable to resist movement of the platform at least one of during a measurement and after a measurement. | 06-04-2009 |
Carla Di Cairano-Gilfedder, London GB
Patent application number | Description | Published |
---|---|---|
20150029887 | SIGNALLING CONGESTION - Methods and apparatus are disclosed for signalling congestion being caused by data items such as packets, received at a network element such as a router, in a communications network such as the Internet, or being caused by items otherwise requiring service or capacity from a shared resource. Preferred embodiments of the method involve identifying whether or not received data items received at a network element are capable of carrying congestion indications such as ECN marks, and for those that are capable, assigning congestion indications to the data items in dependence on a queue length characterisation based on a substantially current, instantaneous measurement of the length of the queue, whereas for those that are not capable, a sanction such as dropping may be applied in dependence on a different queue length characterisation based on a weighted moving average of current, recent, and less recent measurements of the length of the queue. | 01-29-2015 |
Carla Duymelinck, Kruibeke BE
Patent application number | Description | Published |
---|---|---|
20080206807 | Methods, Reagents, Devices and Instrumentation For Preparing Impregnated Tissue Samples Suitable For Histopathological and Molecular Studies - A process for the production of paraffin sections of biological tissue, especially for molecular pathology studies is disclosed. In the process, the tissue sample is simultaneously fixed, dehydrated and cleared in a first step, subsequently dehydrated and cleared in a second step and infiltrated with an inert specimen matrix in a third step. The specimen can then be further embedded in a casting supporting matrix according to the standard procedures followed by any local pathology or research laboratory. A kit and a processing station for automating paraffin embedding of a tissue sample suitable for histopathological and molecular analysis is also described. A bio-indicator system is described for measuring the degree of crosslinking. A tissue sample holding means or a vial which includes a tissue sample holding means provided with a data logging device capable of registering and transmitting data regarding the sample and conditions where the sample was processed is also disclosed. | 08-28-2008 |
20080274496 | Methods, Reagents and Instrumentation for Preparing Impregnated Tissue Samples Suitable for Histopathological and Molecular Studies - A process and kit for the production of paraffin sections of biological tissue, especially for molecular pathology studies, is described. In the process, the tissue sample is simultaneously fixed, dehydrated and cleared in a first step, subsequently dehydrated and cleared in a second step and infiltrated with an inert specimen matrix in a third step. The specimen can then be further embedded in a casting supporting matrix according to the standard procedures followed by any local pathology or research laboratory. The method is uncomplicated, requires little hands-on time, is reproducible and is standardized thereby limiting cross-centre pre-analytical variance. A bio-indicator system for measuring the degree of crosslinking is also disclosed. | 11-06-2008 |
Carla Emolo, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20140037650 | COMPOSITIONS AND METHODS RELATED TO ANTIBODIES TO STAPHYLOCOCCAL PROTEINS ISDA OR ISDB - The present invention concerns methods and compositions for treating or preventing a bacterial infection, particularly infection by a | 02-06-2014 |
20150273040 | COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHYLOCOCCUS AUREUS DISEASE - The present invention concerns methods and compositions for treating or preventing a bacterial infection, particularly infection by a | 10-01-2015 |
20150368322 | COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHYLOCOCCUS AUREUS DISEASE - Embodiments concern methods and compositions for treating or preventing a bacterial infection, particularly infection by a | 12-24-2015 |
20160137749 | Compositions and Methods Related to Antibodies to Staphylococcal Protein A - Embodiments concern methods and compositions for treating or preventing a bacterial infection, particularly infection by a | 05-19-2016 |
Carla Ferragina, Roma IT
Patent application number | Description | Published |
---|---|---|
20110245513 | SYNTHESIS PROCESS OF POLYOL CARBONATE FROM POLYOLS, CONDUCTED IN USING A SOLVENT SELECTIVE FOR POLYOLS CARBONATES - The present invention relates to a synthesis process of polyol carbonate, such as glycerol carbonate, from polyols such as glycerol, propylene glycol or ethylene glycol and urea conducted in using a solvent selective for polyols (glycerol) carbonates. Said process comprises reacting polyol with urea in the presence of a catalyst, extracting produced NH | 10-06-2011 |
Carla Francese, Torino IT
Patent application number | Description | Published |
---|---|---|
20120290122 | PREDICTIVE CONTROL AND VIRTUAL DISPLAY SYSTEM FOR A NUMERICALLY CONTROLLED MACHINE TOOL - A numerically controlled machine tool, and method for control thereof, to display virtual two-dimensional future positions to be adopted by a workpiece and by the machine tool in a pre-set predictive time window. The system and method calculate target coordinate values defining positions of the tool along axes of the machine tool on the basis of a machining program. While machining is in progress, a processor receives the calculated target coordinate values to generate and display image data on the basis of the target coordinate values and of stored mathematical models of the machine, of the workpiece, and of the tool. | 11-15-2012 |
Carla Ghelardini, Candeglia (pistoia) IT
Patent application number | Description | Published |
---|---|---|
20140051730 | THERAPEUTIC USE OF DIMIRACETAM TO PREVENT THE HAND AND FOOT SYNDROME CAUSED BY SORAFENIB - Dimiracetam is a suitable drug for treating and preventing allodynia, in particular allodynia of the hands and feet, that is or may be induced by antitumoral chemotherapeutic treatment with sorafenib. | 02-20-2014 |
Carla Ghelardini, Firenze IT
Patent application number | Description | Published |
---|---|---|
20090163565 | Compounds with nootropic action, their preperation, pharmaceutical compositions containing them, and use thereof - Described herein are new bicyclic arylimidazolones having nootropic action (i.e., protecting and stimulating cerebral functions), analgesic action and anti hyperalgesic action; also described is the process for their preparation and pharmaceutical compositions comprising them, useful for the treatment of cognitive deficits, and of various types of pain. | 06-25-2009 |
20100173945 | Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof - Described herein are new bicyclic arylimidazolones having nootropic action (i.e., protecting and stimulating cerebral functions), analgesic action and anti hyperalgesic action; also described is the process for their preparation and pharmaceutical compositions comprising them, useful for the treatment of cognitive deficits, and of various types of pain. | 07-08-2010 |
Carla Ghelardini, Milano IT
Carla Ghelardini, Pistoia IT
Patent application number | Description | Published |
---|---|---|
20100062077 | PYRROLO[1,2-A]IMIDAZOLEDIONE EFFECTIVE IN THE TREATMENT OF PERIPHERAL NEUROTOXICITY INDUCED BY CHEMOTHERAPEUTIC AGENTS - The use of a compound of formula (I), is disclosed in treating and/or preventing 5 chemotherapy-induced peripheral neurotoxicity (CIPN). The invention includes pharmaceutical compositions wherein the compound of formula (I) is present in a mixture with anticancer agents. An improved anticancer treatment with reduced CIPN-related side effects is also provided. | 03-11-2010 |
20100125096 | Acetam Derivatives for Pain Relief - The present invention provides a method of treatment, prevention and/or delay of progression of neuropathic pain by a specific dosing regime of acetam derivatives. | 05-20-2010 |
20100129469 | USE OF DIMIRACETAM IN THE TREATMENT OF CHRONIC PAIN - The use of dimiracetam in the treatment of chronic pain is disclosed. At doses higher than those previously disclosed in relation with its cognition enhancing activity (i.e. amelioration of learning and memory), dimiracetam was able to completely revert hyperalgesia or allodynia associated with several animal models of chronic pain. Dimiracetam showed high activity in iatrogenic neuropathies associated with antiviral and chemotherapeutic drug treatments and in painful conditions caused by osteoarthritis. In addition, dimiracetam was devoid of toxicity even at doses 10-fold higher than the highest therapeutic dose. The possibility of treating such debilitating pathologies with a highly effective and essentially non-toxic compound is therefore disclosed. | 05-27-2010 |
20110008473 | USE OF HYPERICUM PERFORATUM EXTRACTS IN THE TREATMENT OF NEUROPATHIC PAIN - Disclosed is the use of | 01-13-2011 |
20110015200 | NITROGEN-CONTAINING BYCYCLIC COMPOUNDS ACTIVE ON CHRONIC PAIN CONDITIONS - The invention refers to compounds of general formula (I) wherein the R groups are, independently, H, C | 01-20-2011 |
20110218249 | USE OF HYPERICUM PERFORATUM EXTRACTS IN THE TREATMENT OF NEUROPATHIC PAIN - Disclosed is the use of | 09-08-2011 |
20110251250 | USE OF DIMIRACETAM IN THE TREATMENT OF CHRONIC PAIN - The use of dimiracetam in the treatment of chronic pain is disclosed. At doses higher than those previously disclosed in relation with its cognition enhancing activity (i.e. amelioration of learning and memory), dimiracetam was able to completely revert hyperalgesia or allodynia associated with several animal models of chronic pain. Dimiracetam showed high activity in iatrogenic neuropathies associated with antiviral and chemotherapeutic drug treatments and in painful conditions caused by osteoarthritis. In addition, dimiracetam was devoid of toxicity even at doses 10-fold higher than the highest therapeutic dose. The possibility of treating such debilitating pathologies with a highly effective and essentially non-toxic compound is therefore disclosed. | 10-13-2011 |
20130072533 | COMPOUNDS WITH BOTH ANALGESIC AND ANTI-HYPERALGESIC EFFICACY - The present invention relates to molecules of formula (I), deriving from lipoic acid and camosine, their preparation and use as analgesics. | 03-21-2013 |
Carla Giumaraes, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20150031604 | CYCLIC POLYPEPTIDES FOR THE TREATMENT OF HEART FAILURE - The invention provides a cyclic polypeptide of Formula I (SEQ ID NO: 1): | 01-29-2015 |
Carla Grandori, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20110166200 | METHODS OF USING MIR210 AS A BIOMARKER FOR HYPOXIA AND AS A THERAPEUTIC AGENT FOR TREATING CANCER - The present invention provides compositions and methods for predicting the hypoxia response in tumor cells, methods for predicting the likelihood of cancer metastasis, and methods for inhibiting tumor cell proliferation using a microRNA comprising miR-210. | 07-07-2011 |
20130115309 | METHODS FOR IDENTIFYING AND USING INHIBITORS OF CASEIN KINASE 1 EPSILON ISOFORM FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS - In one aspect, the invention provides a method for inhibiting the growth and/or proliferation of a myc-driven tumor cell comprising the step of contacting the tumor cells with a CSNK1ε inhibitor. In another aspect, the invention provides a method of treating a subject suffering from a tumor comprising myc-driven tumor cells, comprising administering to the subject an amount of a composition comprising a CSNK1ε inhibitor effective to inhibit the growth and/or proliferation of the tumor cells. | 05-09-2013 |
20150148401 | METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS - The invention generally relates to methods for identifying and using anticancer therapeutic agents and, more particularly, to methods for identifying and using inhibitors of genes for inhibiting the growth and/or proliferation of MYC-driven tumor cells relative to normal cells. | 05-28-2015 |
Carla Green, Shawnee, OK US
Patent application number | Description | Published |
---|---|---|
20100257674 | Method for positioning a human subject for radiological imaging, surgery or minimally invasive procedures using an inflatable contoured pillow - An ergonomic pillow for supporting and positioning a human subject on an imaging table having one or more inflatable chambers, and methods of use. | 10-14-2010 |
Carla Kantara, Dickinson, TX US
Patent application number | Description | Published |
---|---|---|
20150359855 | METHODS OF USING THROMBIN DERIVATIVES TO TREAT MEDULLOBLASTOMA - Provided herein are methods for using a thrombin peptide derivative to treat a medulloblastoma. In one embodiment, the method includes administering to a subject having a medulloblastoma an effective amount of a thrombin peptide derivative, and exposing cells of the medulloblastoma of the subject to a cancer treatment after administering the thrombin peptide derivative to the subject. An example of a cancer treatment is radiation therapy. In one embodiment, viability of cells of the medulloblastoma is decreased compared to viability of cells of the medulloblastoma before the administering and the exposing. The cells of the medulloblastoma having decreased viability can be cancer stem cells. In one embodiment, shrinkage of the medulloblastoma in the subject is increased compared to shrinkage of the medulloblastoma before the administering and the exposing. | 12-17-2015 |
Carla Knoop, Stuttgart NL
Patent application number | Description | Published |
---|---|---|
20080301587 | Control System for a Motor Vehicle - A control system for a motor vehicle having a manual operating means having a plurality of adjustment degrees of freedom for selecting and/or activating entries in a menu structure having a plurality of menu levels, and a screen display ( | 12-04-2008 |
Carla Kohoyda-Inglis, Grass Lake, MI US
Patent application number | Description | Published |
---|---|---|
20140064583 | Analytic Morphomics: High Speed Medical Image Automated Analysis Method - A computer-implemented method is provided for anatomically indexing a subject. The method includes: receiving image scan data representing a volume of a subject, where the image scan data is comprised of a plurality of image slices of the subject and includes at least a portion of a vertebral column of the subject; identifying the vertebral canal of the vertebral column of the subject in the image scan data; determining a plurality of markers for the vertebral column, where each marker is indicative of a different vertebral body of the vertebral column and includes its location in the image scan data defined in a coordinate system, such that the plurality of markers define a vertebral level coordinate system; and storing each marker along with its location in a database. The markers can subsequently be used to reference other anatomical components of the subject across different image scans. | 03-06-2014 |
Carla Labruzzo, Milano IT
Patent application number | Description | Published |
---|---|---|
20130079399 | NOVEL DERIVATIVES OF MESALAZINE, PROCESS OF THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASES - The present invention refers to the compounds corresponding to the following general formula (I): | 03-28-2013 |
Carla Labruzzo, Milano (mi) IT
Patent application number | Description | Published |
---|---|---|
20130142880 | BECLOMETHASONE DIPROPIONATE COMPOSITIONS IN MODIFIED-RELEASE GASTRO-RESISTANT MICROSPHERES AND PROCESS FOR OBTAINING THEM - The present invention refers to pharmaceutical beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and to their oral use in the treatment of inflammatory pathologies of the intestinal tract. Said compositions in microspheres comprise: a) a core consisting of a microsphere of inert material; b) a first intermediate coating comprising beclomethasone dipropionate and at least one physiologically acceptable excipient; c) a second modified-release gastro-resistant coating. The present invention also refers to a process for obtaining said compositions. | 06-06-2013 |
Carla Labzzuo, Milan IT
Patent application number | Description | Published |
---|---|---|
20120141592 | CONTROLLED-RELEASE GRANULAR COMPOSITIONS CONTAINING MESALAZINE AND PROCESS FOR THE MANUFACTURE THEREOF - The present invention refers to controlled release granular compositions of mesalazine and their use in the treatment of inflammatory pathologies of the intestinal tract. The aforesaid granular compositions comprise: a) a central core comprising an inert substrate; b) an intermediate layer comprising mesalazine and one or more physiologically acceptable excipients; c) a gastro-resistant coating. The present invention then refers to a process for obtaining the aforesaid granular compositions. | 06-07-2012 |
Carla Lanuza Cerzocimo, Huesca ES
Patent application number | Description | Published |
---|---|---|
20110313321 | METHOD AND DEVICE FOR OBTAINING A PLANTAR IMAGE AND DOUBLE-SIDED MACHINING OF THE INSOLE THUS OBTAINED - Method for obtaining a plantar image using means for securing and tightening an elastic membrane, as well as to the double-sided machining of the obtained insole, said means taking the form of two adjustable horizontal bars positioned on a scanner or a plurality of cameras and an anti-reflective lens, wherein a membrane is positioned between said horizontal bars and secured using T-flat bars; the stress of the membrane being adjusted using a handle; the foot is positioned on the membrane; an image is taken; and the insole is subjected to double-sided machining on the basis of the image of the surface provided in STL format, with the aid of a securing device that enables the pieces to be rotated up to | 12-22-2011 |
Carla Leighow, Grain Valley, MO US
Patent application number | Description | Published |
---|---|---|
20120168492 | PROTOCOL DRIVEN IMAGE ACQUISITIION - Systems, methods, and computer-readable media having computer-executable instructions embodied thereon for protocol driven image acquisition are provided. In embodiments, a protocol is received by an image capturing device. The protocol comprises orders from a clinician, a workflow for capturing at least one image, or a combination thereof. At least one field for receiving metadata to be associated with the at least one image allows structured documentation to begin on the image capturing device. The at least one image and associated metadata are communicated to a medical information system. A patient is identified by the metadata or an existing patient to device association and the at least one image is associated with an electronic medical record for the patient. | 07-05-2012 |
20120173278 | PREPOPULATING CLINICAL EVENTS WITH IMAGE BASED DOCUMENTATION - Systems, methods, and computer-readable media having computer-executable instructions embodied thereon for protocol driven image acquisition are provided. In embodiments, a protocol is received by an image capturing device. The protocol comprises orders from a clinician, a workflow for capturing at least one image, or a combination thereof. At least one field for receiving metadata to be associated with the at least one image allows structured documentation to begin on the image capturing device. The at least one image and associated metadata are communicated to a medical information system. A patient is identified by the metadata or an existing patient to device association and the at least one image is associated with an electronic medical record for the patient. | 07-05-2012 |
20130108126 | MULTI-IMAGE VIEWER FOR MULTI-SOURCED IMAGES | 05-02-2013 |
20130110543 | TIMELINE FOR MULTI-IMAGE VIEWER | 05-02-2013 |
20130317857 | PREPOPULATING CLINICAL EVENTS WITH IMAGE BASED DOCUMENTATION - Systems, methods, and computer-readable media having computer-executable instructions embodied thereon for protocol driven image acquisition are provided. In embodiments, a protocol is received by an image capturing device. The protocol comprises orders from a clinician, a workflow for capturing at least one image, or a combination thereof. At least one field for receiving metadata to be associated with the at least one image allows structured documentation to begin on the image capturing device. The at least one image and associated metadata are communicated to a medical information system. A patient is identified by the metadata or an existing patient to device association and the at least one image is associated with an electronic medical record for the patient. | 11-28-2013 |
Carla Lintas, Rome IT
Patent application number | Description | Published |
---|---|---|
20100227324 | MEASUREMENT OF ARYLESTERASE ENZYMATIC ACTIVITY AND ASSESSMENT OF GENETIC POLYMORPHISMS LOCATED IN THE PON1 GENE AS A DIAGNOSTIC TOOL IN AUTISM-SPECTRUM DISORDERS - The present invention concerns a method for detecting the presence of or predisposition to autism, an autism spectrum disorder, or an autism-associated disorder in a subject, the method comprising measuring an arylesterase enzymatic activity in a sample from the subject, optionally combined with the determination of alleles of PON1 polymorphisms. | 09-09-2010 |
Carla Mann Woods, Beverly Hills, CA US
Patent application number | Description | Published |
---|---|---|
20090248096 | OPERATING ROOM LEAD CONNECTOR - An operating room connector is used in conjunction with a multiple electrode SCS system which can easily detach and connect to an external trial stimulator (ETS). By connecting the electrode SCS system to a stylet handle, and then locking the stylet handle within a slot of the connector platform, a user is able to minimize the required steps in connecting the ETS to the implanted SCS lead system. The ETS can then be used to readjust the position of the electrode array(s) previously implanted to deliver an optimal stimulation therapy. | 10-01-2009 |
20100046778 | INTEGRATED COCHLEAR IMPLANT HEADPIECE - An integrated headpiece for a cochlear implant system includes a microphone for outputting an audio signal; signal processing electronics for processing the audio signal; and a transmitter for transmitting a processed audio signal received from the electronics to an implanted receiver. All of the microphone, signal processing electronics, and transmitter are disposed in a common housing of the integrated headpiece. The headpiece may also be one of a set of headpieces that can be alternatively used as needed to suit power consumption requirements or environmental conditions. | 02-25-2010 |
20100046779 | MODULAR SPEECH PROCESSOR HEADPIECE - A cochlear implant system includes: an electrode array implanted within a cochlea; an internal processor in communication with the electrode array; an implanted antenna which is electrically coupled to the internal processor; and a modular external headpiece which is removably positioned over the implanted antenna, the modular external headpiece including a core containing a sound processor for processing sound and providing a corresponding signal to the implanted antenna; and a modular component configured to releasably engage the core and supply electrical power to the core. A modular speech processor headpiece includes a core comprising a microphone and sound processor for producing a signal representing ambient sound to be transmitted to a cochlear implant, the core further comprising a number of electrical contacts; and a modular component containing a number of electrical contacts corresponding to the electrical contacts of the core; wherein the core is configured to engage with the modular component such that electrical communication is made between the core and the modular component. | 02-25-2010 |
20100280572 | OPEN LOOP DEEP BRAIN STIMULATION SYSTEM FOR THE TREATMENT OF PARKINSON'S DISEASE OR OTHER DISORDERS - A deep brain stimulation (DBS) system ( | 11-04-2010 |
20120041517 | SPEECH PROCESSOR CASES - Apparatus and methods for converting one type of speech processor unit into another type of speech processor unit. | 02-16-2012 |
20120184907 | Infusion Pumps - Ambulatory infusion pumps, pump assemblies, and baseplate assemblies, including cartridges, baseplates, cannulas, inserters, and related components and batteries therefor, as well as component combinations and related methods. | 07-19-2012 |
20120276767 | OPERATING ROOM LEAD CONNECTOR - An operating room connector is used in conjunction with a multiple electrode SCS system which can easily detach and connect to an external trial stimulator (ETS). By connecting the electrode SCS system to a stylet handle, and then locking the stylet handle within a slot of the connector platform, a user is able to minimize the required steps in connecting the ETS to the implanted SCS lead system. The ETS can then be used to readjust the position of the electrode array(s) previously implanted to deliver an optimal stimulation therapy. | 11-01-2012 |
20120330378 | Modular Speech Processor Headpiece - A cochlear implant system includes: an electrode array implanted within a cochlea; an internal processor in communication with the electrode array; an implanted antenna which is electrically coupled to the internal processor; and a modular external headpiece which is removably positioned over the implanted antenna, the modular external headpiece including a core containing a sound processor for processing sound and providing a corresponding signal to the implanted antenna; and a modular component configured to releasably engage the core and supply electrical power to the core. A modular speech processor headpiece includes a core comprising a microphone and sound processor for producing a signal representing ambient sound to be transmitted to a cochlear implant, the core further comprising a number of electrical contacts; and a modular component containing a number of electrical contacts corresponding to the electrical contacts of the core; wherein the core is configured to engage with the modular component such that electrical communication is made between the core and the modular component. | 12-27-2012 |
20130116747 | MODULAR SPEECH PROCESSOR HEADPIECE - A cochlear implant system includes: an electrode array implanted within a cochlea; an internal processor in communication with the electrode array; an implanted antenna which is electrically coupled to the internal processor; and a modular external headpiece which is removably positioned over the implanted antenna, the modular external headpiece including a core containing a sound processor for processing sound and providing a corresponding signal to the implanted antenna; and a modular component configured to releasably engage the core and supply electrical power to the core. A modular speech processor headpiece includes a core comprising a microphone and sound processor for producing a signal representing ambient sound to be transmitted to a cochlear implant, the core further comprising a number of electrical contacts; and a modular component containing a number of electrical contacts corresponding to the electrical contacts of the core; wherein the core is configured to engage with the modular component such that electrical communication is made between the core and the modular component. | 05-09-2013 |
20140169602 | Speech Processor Cases - Apparatus and methods for converting one type of speech processor unit into another type of speech processor unit. | 06-19-2014 |
20150073386 | Infusion Pumps - Ambulatory infusion pumps, pump assemblies, and baseplate assemblies, including cartridges, baseplates, cannulas, inserters, and related components and batteries therefor, as well as component combinations and related methods. | 03-12-2015 |
20150181354 | SPEECH PROCESSOR HEADPIECE - A cochlear implant system includes: an electrode array implanted within a cochlea; an internal processor in communication with the electrode array; an implanted antenna which is electrically coupled to the internal processor; and a modular external headpiece which is removably positioned over the implanted antenna, the modular external headpiece including a core containing a sound processor for processing sound and providing a corresponding signal to the implanted antenna; and a modular component configured to releasably engage the core and supply electrical power to the core. A modular speech processor headpiece includes a core comprising a microphone and sound processor for producing a signal representing ambient sound to be transmitted to a cochlear implant, the core further comprising a number of electrical contacts; and a modular component containing a number of electrical contacts corresponding to the electrical contacts of the core; wherein the core is configured to engage with the modular component such that electrical communication is made between the core and the modular component. | 06-25-2015 |
20160142835 | SPEECH PROCESSOR CASES - Apparatus and methods for converting one type of speech processor unit into another type of speech processor unit. | 05-19-2016 |
Carla Marcenaro, Genova IT
Patent application number | Description | Published |
---|---|---|
20130182608 | NETWORK MANAGEMENT UTILIZING TOPOLOGY ADVERTISEMENTS - A network management node of a connection-oriented network listens to topology advertisements in a control plane of the network and stores information carried in the topology advertisements. The node selectively sends Link Management Protocol (LMP) requests based on the information carried in the topology advertisements. The LMP requests can be performed for at least one of the following events: adjacency addition; addition of a link between nodes; deletion of a link between nodes; modification to the bandwidth of a link between nodes. The information collected in the topology advertisements is translated into a format compatible with an Operations Support System (OSS) model. | 07-18-2013 |
20150016815 | ADDING NEW ALTERNATIVE PATHS FOR RESTORATION IN WSON NETWORK - A network management system manages preplanned alternative paths in a wavelength switched optical network for a traffic flow having a working path and two or more preplanned alternative paths from a source node to a destination node. A processing part determines if, after the fault, a number of available alternative paths for the respective traffic flow drops to a threshold. If so, a new alternative path is calculated and set up the new alternative path in the nodes, to enable one or more of the nodes to move the traffic flow onto the new alternative path in the event of further faults without waiting for input from the network management system. Thus multiple faults can be handled without the nodes needing to store details of so many such alternative paths. Otherwise, many such alternative paths are needed to take account of many different possible failure locations. | 01-15-2015 |
20150055486 | MONITORING CARRIER ETHERNET NETWORKS - A Carrier Ethernet network comprises nodes connected by links. The network supports connectionless traffic flows between nodes. A network management system performs a method comprising: determining when an event has occurred in the network which may change bandwidth usage on a link of the network; determining traffic flows which use the link; determining a total bandwidth demand of the traffic flows using the link; and comparing the total bandwidth demand with a bandwidth capacity of the link. Determining when the event has occurred can include at least one of: receiving an alarm indicating a network fault; receiving a topology change indication from a node of the network. | 02-26-2015 |
20150163094 | METHOD OF AND APPARATUS FOR CONFIGURING A LINK IN A LABEL SWITCHING COMMUNICATION NETWORK - The present invention relates to a method of and apparatus for configuring a link in a label switching communication network. The method implemented in a network node comprises determining formation of a communication link between the network node and another network node and sending link formation information to a link manager. The method further comprises receiving link configuration information for the communication link from the link manager and configuring the communication link in response to the received link configuration information. | 06-11-2015 |
20150215032 | Apparatus and Method for Optimizing the Reconfiguration of an Optical Network - There is provided a method for optimizing the configuration of an optical network which is adapted to transport optical traffic along a path from a source node to a destination node, wherein the path can be routed via any one or more of a plurality of intermediate nodes in the optical network. The method comprises the steps of receiving an operating parameter of an optical device monitored in a plurality of nodes. The received operating parameter is compared with a threshold value. An operating status of a node is determined based on the comparison of the received operating parameter with the threshold value. The determined operating status of a node is used as a routing criteria for computing a path for routing traffic through the optical network. | 07-30-2015 |
20150244464 | Operating a Node in an Optical Transport Network - An optical transport network ( | 08-27-2015 |
20150341245 | NETWORK MANAGEMENT MODEL EXTENSION - A communications network has network elements and management parts and a stored model of the network. The network elements have a controllable energy consumption status represented explicitly in the stored model. Indications of the controllable energy consumption status are passed between the management parts and network elements in a format which is compatible with the format of the model, such as by extension of TMF 814. Representing such energy status information more explicitly means it can be exchanged or distributed more efficiently, and passing the indication in a format compatible with a standard format of the network model, means a discovery request can be more easily used at various different management levels, and by various different parts of the network. | 11-26-2015 |
Carla Marcenaro, Genoa IT
Patent application number | Description | Published |
---|---|---|
20130051788 | PATH DISCOVERY IN A COMMUNICATIONS NETWORK - The invention relates to discovering a path in a communications network. Embodiments of the invention disclose determining whether at least two server trail termination points (TTPs) of the path are compatible, creating a server trail between the at least two TTPs, determining whether each TTP is framed by a respective client connection termination point (CCTP) of a higher layer, assigning a respective CCTP to each of the two TTPs, creating a link connection between the respective CCTPs, determining if one of the respective CCTPs is associated with a higher layer TTP, and if it is not so associated then determining if one of the respective CCTPs is constrained to a single TTP. The embodiments of the invention allow paths in a network to be determined after a change has taken place or a physical link has been created. | 02-28-2013 |
20150236920 | METHOD AND APPARATUS FOR DETERMINING CONNECTION INFORMATION OF A LINK - A method and apparatus is provided for determining connection information of a link between a first port on a first network element and a second port on a second network element. Bidirectional Forwarding Detection discriminator values are defined for both the first port and the second port, BFD signals are sent over the link, and a link connection profile is produced containing the first and second BFD discriminator values. The link connection profile is notified to a network management system, which may then update the network topology with the link connection information. | 08-20-2015 |
Carla Maria Sanches Scanavez De Paula, Campinas BR
Patent application number | Description | Published |
---|---|---|
20140216492 | METHOD FOR ASSESSING HAIR CONDITIONS AND DIAGNOSTIC SYSTEM FOR PRESCRIPTION OF CUSTOMIZED COSMETIC TREATMENT AND/OR PRODUCT - It describes a method for assessing hair conditions, conceived to prescribe a customized cosmetic treatment and/or product, comprising the following steps: A) obtaining information about the hair of at least one user by means of at least one questionnaire with at least one question that combines parameters of tactile perception of hair with at least three attributes, defined by softness, combing and coarseness; B) inserting the information obtained in step A in a matrix for classification of hair damages, in order to obtain at least one classification about the hair conditions of the user; C) associating the classification about the hair condition of the user obtained in step B with the characteristics of at least one cosmetic product stored in a database that stores registrations of at least one cosmetic product, in order to obtain at least one result about the customized cosmetic treatment and/or product; and D) prescribing to the user at least one customized cosmetic treatment and/or product according to the result obtained in step C. It is also describes a system for diagnosing the hair conditions by using at least one matrix for classification of hair damages and one database. | 08-07-2014 |
Carla Mazzucchetti, San Mauro Torinese IT
Patent application number | Description | Published |
---|---|---|
20120160616 | BRAKE PAD FOR VEHICLE DISC BRAKE - A brake pad ( | 06-28-2012 |
Carla Mcnearny, Arvada, CO US
Patent application number | Description | Published |
---|---|---|
20100262550 | INTER-CORPORATE COLLABORATION OVERLAY SOLUTION FOR PROFESSIONAL SOCIAL NETWORKS - A service provider includes a broker. The broker receives a request from a business organization requester for one or more potential collaborators in a determined subject matter area; accesses one or more personal profiles maintained by one or more social network services; selects a subset of individuals described in the accessed profiles as being of potential interest to the requester; and provides to the requestor information describing the members of the subset of individuals. | 10-14-2010 |
20120110083 | Inter-Corporate Collaboration Overlay Solution for Professional Social Networks - A service provider includes a broker. The broker receives a request from a business organization requestor for one or more potential collaborators in a determined subject matter area; accesses one or more personal profiles maintained by one or more social network services; selects a subset of individuals described in the accessed profiles as being of potential interest to the requestor; and provides to the requestor information describing the members of the subset of individuals. | 05-03-2012 |
Carla Meledandri, Murrysville, PA US
Patent application number | Description | Published |
---|---|---|
20120282182 | NANOPARTICLE CLUSTERS FORMED FROM INDIVIDUAL NANOPARTICLES OF TWO OR MORE TYPES - Nanoparticle clusters are described. In particular nanoparticle clusters formed from two or more individual nanoparticles of different types are described and methods for fabricating such nanoparticle clusters are further described. These nanoparticle clusters are fabricated by surface activating individual ones of the plurality of nanoparticles by desorption of surfactant molecules from the surface of the coated nanoparticles through exposure of the individual ones of the plurality of nanoparticles to an activating agent. | 11-08-2012 |
Carla Minarini, Salerno IT
Patent application number | Description | Published |
---|---|---|
20090066244 | Encapsulated Organic Electronic Device With Improved Resistance To Degradation - An encapsulated organic electronic device is provided with: a substrate; at least one first elementary component and one second elementary component set above the substrate, each of said first and second elementary components being provided with a respective first electrode set above the substrate, a respective region of organic material set above the first electrode, and a respective second electrode set above the region of organic material at least partially in an area corresponding to the first electrode; and an encapsulation structure, defining an encapsulation space isolated from an external environment and designed to protect the first and second elementary components from the external environment. In particular, the regions of organic material of the first and second elementary components are separated and distinct from one another and are set entirely within the encapsulation space. | 03-12-2009 |
Carla Miner, Carp CA
Patent application number | Description | Published |
---|---|---|
20090046222 | Electroluminescent Films for Backlighting Liquid Crystal Displays - The present invention replaces the conventional cold cathode fluorescent tubes used in backlighting units of liquid crystal displays with an integrated electro-luminescent film structure, subdivided into electrically isolated micro-panels. Ideally, the electro-luminescent structure comprises separate red, green and blue micro-panels providing full color capabilities. Alternatively, the electro-luminescent film structure includes stacked groups of layers, in which each group emits a different color and is independently controllable. | 02-19-2009 |
20100032687 | ENGINEERED STRUCTURE FOR HIGH BRIGHTNESS SOLID-STATE LIGHT EMITTERS - Electroluminescent (EL) light emitting structures comprises one or more active layers comprising rare earth luminescent centres in a host matrix for emitting light of a particular colour or wavelength and electrodes for application of an electric field and current injection for excitation of light emission. The host matrix is preferably a dielectric containing the rare earth luminescent centres, e.g. rare earth doped silicon dioxide, silicon nitride, silicon oxynitrides, alumina, dielectrics of the general formula Si | 02-11-2010 |
20100033111 | ELECTROLUMINESCENT FILMS FOR BACKLIGHTING LIQUID CRYSTAL DISPLAYS - The present invention replaces the conventional cold cathode fluorescent tubes used in backlighting units of liquid crystal displays with an integrated electro-luminescent film structure, subdivided into electrically isolated micro-panels. Ideally, the electro-luminescent structure comprises separate red, green and blue micro-panels providing full color capabilities. Alternatively, the electro-luminescent film structure includes stacked groups of layers, in which each group emits a different color and is independently controllable. | 02-11-2010 |
20110024819 | HIGH QUALITY GATE DIELECTRIC FOR SEMICONDUCTOR DEVICES AND METHOD OF FORMATION THEREOF - Improved high quality gate dielectrics and methods of preparing such dielectrics are provided. Preferred dielectrics comprise a rare earth doped dielectric such as silicon dioxide or silicon oxynitride. In particular, cerium doped silicon dioxide shows an unexpectedly high charge-to-breakdown Q | 02-03-2011 |
Carla Nelson, Burnsville, MN US
Patent application number | Description | Published |
---|---|---|
20100325087 | TEST STRATEGY SYSTEM AND METHOD FOR ACCOUNTS HELD DIRECT AT-FUND - The present invention provides a system and method for a user to test and transfer data from a client's database or network to a host's database or network. In accordance with an exemplary embodiment of the present invention, a user acquires data information from a client. The user uses this information to generate a spreadsheet, and to populate the spreadsheet with assumed values based on the information received from the client. The spreadsheet is configured in a fashion such that it is consistent with the host's database or network. The user requests and receives a test file from the client and uses a developed algorithm, generally in the form of a computer program, to reformat the file so that it is consistent with the host's database configuration. The user determines the consistency between the reformatted file and the host's database by comparing the reformatted file to the previously generated spreadsheet. Any inconsistencies identified alert the user that the file reformatting algorithm needs updating. When all the updates are complete and the reformatting algorithm has been deemed appropriate to carry out the data transformation function, the entire client database log is sent to the user in the form of an input file. The input file is duplicated to protect the original information and then reformatted using the updated algorithm. The reformatted file may then be uploaded to the host's network or database so that the information contained may be used by others who access the database or network for information. | 12-23-2010 |
20120011154 | TEST STRATEGY SYSTEM AND METHOD FOR ACCOUNTS HELD DIRECT AT-FUND - A system and method for a user to test and transfer data from a client's database or network to a host's database or network is disclosed. A user acquires data information from a client and the user uses this information to generate a spreadsheet, and to populate the spreadsheet with assumed values based on the information received from the client. The user requests and receives a test file from the client and uses a developed algorithm to reformat the file so that it is consistent with the host's database configuration. The user determines the consistency between the reformatted file and the host's database by comparing the reformatted file to the previously generated spreadsheet. Any inconsistencies identified alert the user that the file reformatting algorithm needs updating. | 01-12-2012 |
Carla Oncins Bergas, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20110195103 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION CONTAINING PSEUDOALTEROMONAS FERMENT EXTRACT - Cosmetic or dermopharmaceutical compositions containing | 08-11-2011 |
Carla Peinknagura, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20080208213 | Devices and methods for the controlled formation and closure of vascular openings - The present invention includes systems, devices and methods for percutaneously forming an aperture within a tissue structure or vessel and closing the aperture in a manner which optimizes hemostasis and healing. The invention in one aspect includes implantable devices which are used to seal the tissue aperture upon closure of the aperture after a percutaneous or endovascular procedure. | 08-28-2008 |
Carla Pienknagura, San Carlos, CA US
Patent application number | Description | Published |
---|---|---|
20090291196 | Abluminal Stent Coating Apparatus And Method Using A Brush Assembly - The apparatus and method use an optical feedback system to align a brush assembly with a stent strut. Once alignment is achieved, a coating is dispensed onto the stent strut via the brush assembly and the brush assembly is moved along the stent strut to coat the stent strut. | 11-26-2009 |
20130186327 | Stent Coating Apparatus with Fibers - A stent coating apparatus for coating a stent includes a brush assembly, a stent support, and a dispensing mechanism. The brush assembly includes a plurality of fibers, and the stent support carries a stent at a position in which the stent is in contact with the fibers. The dispensing mechanism dispenses a coating composition to the plurality of fibers. | 07-25-2013 |
Carla Samolej, Bolingbrook, IL US
Patent application number | Description | Published |
---|---|---|
20110011989 | Holder for flexible elongate conduits - A holder for securing flexible elongate conduits to a post includes a first holding member defined by first and second arms that extend from a first base and a second holding member defined by third and fourth arms that extend from a second base. The first and second bases are attached to one another. A first plane generally bisects the first holding member and is generally equidistant from the first and second arms along an entire longitudinal extent of the first holding member. A second plane generally bisects the second holding member and is generally equidistant from the third and fourth arms along an entire longitudinal extent of the second holding member. The first and second planes are generally perpendicular. | 01-20-2011 |
Carla Sibella, Paris FR
Patent application number | Description | Published |
---|---|---|
20110312006 | Enzymatic Assay for the Quantitative Determination of Phospholipase A1 or A2 Activity in a Sample - The invention relates to a new method for measuring a calcium-dependent phospholipase A1 or A2 enzymatic activity in a sample, comprising the following steps: a) contacting said sample with a solid phase coated with a fluorochrome-labelled phospholipase A1 or A2 substrate, wherein the molecular coverage is in the range 8 to 30 fluorochrome-labelled phospholipase A1 or A2 substrate molecules/nm2 in conditions where calcium-dependent phospholipase A1 or A2 enzymatic activity is blocked. b) reading the fluorescence emission overtime c) adding a solution to initiate calcium-dependent phospholipase A1 or A2 enzymatic activity d) reading the fluorescence emission overtime, and kits for carrying out said method. | 12-22-2011 |
20110312008 | Enzymatic Assay for the Quantitative Determination of Phospholipase A1 or A2 Activity in a Sample - The invention relates to a new method for measuring phospholipase A1 or A2 activity in a sample, using a solid phase coated with a fluorochrome-labelled phospholipase A1 or A2 substrate, wherein the molecular coverage is in the range from 8 to 30 fluorochrome-labelled phospholipase A1 or A2 substrate molecules/nm2, and kit for carrying out said method. | 12-22-2011 |
Carla Stacchino, Torino IT
Patent application number | Description | Published |
---|---|---|
20080249619 | CARDIAC-VALVE PROSTHESIS - A cardiac-valve prosthesis which can be used, for example, as a valve for percutaneous implantation. The prosthesis includes an armature for anchorage of the valve prosthesis in the implantation site. The armature defines a lumen for passage of the blood flow and supports a set of prosthetic valve leaflets, which, under the action of the blood flow, are able to move into a radially divaricated condition to enable the flow of the blood through the lumen in a first direction and a radially contracted condition, in which the valve leaflets co-operate with one another and block the flow of the blood through the prosthesis in the opposite direction. The armature includes, in one embodiment, two annular elements connected by anchor members having the capacity of projecting radially with respect to the prosthesis, and support members for the set of leaflets, the support members being carried by at least one of the annular elements so as to leave substantially disengaged the aforesaid lumen for passage of the blood. | 10-09-2008 |
20080255662 | MINIMALLY-INVASIVE CARDIAC-VALVE PROSTHESIS - A cardiac-valve prosthesis is adapted for percutaneous implantation. The prosthesis includes an armature adapted for deployment in a radially expanded implantation position, the armature including a support portion and an anchor portion, which are substantially axially coextensive with respect to one another. A set of leaflets is coupled to the support portion. The leaflets can be deployed with the armature in the implantation position. The leaflets define, in the implantation position, a flow duct that is selectably obstructable. The anchor portion can be deployed to enable anchorage of the cardiac-valve prosthesis at an implantation site. | 10-16-2008 |
20080262603 | PROSTHETIC HEART VALVE HOLDER - A holder for prosthetic heart valves including an annular base and prosthetic valve leaflets extending between commissure regions oriented axially with respect to the base. The holder includes a grip element from which a plurality of arms extend for supporting the prosthetic heart valve in an intermediate position between the commissures. Protecting formations extend radially with respect to the grip element to protect the commissure regions. The grip element includes a first rotational element for coupling to a handle and at least one second coupling element for coupling the grip element of the holder to a support element thereby impeding its rotation. | 10-23-2008 |
20120172982 | CARDIAC VALVE PROSTHESIS - A cardiac valve prosthesis includes a frame and a set of prosthetic valve leaflets supported by the frame. The frame defines a principal axis of the cardiac valve prosthesis and includes first and second annular elements expandable from a radially contracted state to a radially expanded state, a plurality of valve supports supporting the leaflets, and a plurality of connecting members. The valve supports are angularly spaced from one another about the principal axis of the cardiac valve prosthesis, and the connecting members extend between and connect the first and second annular elements. When the annular elements are in the radially expanded state each of the connecting members arches radially outward with respect to the annular elements and is configured to project into one of the Valsalva sinuses when implanted. The connecting members are angularly spaced from the valve supports about the principal axis. | 07-05-2012 |
20130325112 | MINIMALLY-INVASIVE CARDIAC-VALVE PROSTHESIS - A cardiac-valve prosthesis is adapted for percutaneous implantation. The prosthesis includes an armature adapted for deployment in a radially expanded implantation position, the armature including a support portion and an anchor portion, which are substantially axially coextensive with respect to one another. A set of leaflets is coupled to the support portion. The leaflets can be deployed with the armature in the implantation position. The leaflets define, in the implantation position, a flow duct that is selectably obstructable. The anchor portion can be deployed to enable anchorage of the cardiac-valve prosthesis at an implantation site. | 12-05-2013 |
20130345800 | CARDIAC VALVE PROSTHESIS - A method of repairing a native cardiac valve such as the aortic valve includes positioning a cardiac valve prosthesis at an implantation site proximate the native cardiac valve to be repaired. The cardiac valve prosthesis includes an armature and a plurality of prosthetic valve leaflets, the armature including first and second annular elements, a plurality of anchor members extending between the first and second annular elements, and a plurality of valve support members extending from at least one of the first and second annular elements, the plurality of prosthetic valve leaflets being coupled to and supported by the valve support members. The method further includes radially expanding the cardiac valve prosthesis such that each of the anchor members arches radially outward from the first annular element to the second annular element and engages a wall of a respective one of a plurality of native Valsalva sinuses located distal to the native cardiac valve so as to enable anchorage of the cardiac valve prosthesis at the implantation site. | 12-26-2013 |
20150148895 | CARDIAC VALVE PROSTHESIS - A method of repairing a native cardiac valve such as the aortic valve includes positioning a cardiac valve prosthesis at an implantation site proximate the native cardiac valve to be repaired. The cardiac valve prosthesis includes an armature and a plurality of prosthetic valve leaflets, the armature including first and second annular elements, a plurality of anchor members extending between the first and second annular elements, and a plurality of valve support members extending from at least one of the first and second annular elements, the plurality of prosthetic valve leaflets being coupled to and supported by the valve support members. The method further includes radially expanding the cardiac valve prosthesis such that each of the anchor members arches radially outward from the first annular element to the second annular element and engages a wall of a respective one of a plurality of native Valsalva sinuses located distal to the native cardiac valve so as to enable anchorage of the cardiac valve prosthesis at the implantation site. | 05-28-2015 |
Carla Staeben, Tewksbury, MA US
Patent application number | Description | Published |
---|---|---|
20150134591 | METHOD, APPARATUS, AND COMPUTER PROGRAM PRODUCT FOR DATA QUALITY ANALYSIS - A system is disclosed to evaluate data quality in a big data environment. An example method performed by the system includes retrieving one or more rules from an asset catalog. The method further includes retrieving, based on the one or more rules, counter information from a data set, and generating, by a processor, one or more metrics based on the one or more rules and the counter information. In addition, the method includes evaluating, by the processor, the one or more metrics based on the one or more rules. In an instance in which evaluation of a particular metric of the one or more metrics identifies an attribute value that exceeds a predetermined threshold, the method includes causing a notification message regarding the particular metric to be output. A corresponding apparatus and computer program product are also provided. | 05-14-2015 |
Carla Zampaglione, Hawthorn AU
Patent application number | Description | Published |
---|---|---|
20140287105 | BEVERAGE FILTER SYSTEMS - A beverage filter cartridge comprising a cup portion; a lid portion coupled to the cup portion to define an interior; and a filter member provided within the interior; wherein the cup portion, the lid portion, and/or the filter member define three separate compartments with the interior. | 09-25-2014 |
Carla Zoja, Bergamo IT
Patent application number | Description | Published |
---|---|---|
20120309723 | PURINE AND PYRIMIDINE CDK INHIBITORS AND THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISEASES - The present invention relates to the use of an inhibitor of CDK2 and/or CDK7 and/or CDK9, or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for treating a disease associated with antinuclear antibodies, wherein the inhibitor of CDK2 and/or CDK7 and/or CDK9 or pharmaceutically acceptable salt thereof is administered in an amount sufficient to down-regulate the levels of antinuclear antibodies. A further aspect of the invention relates to a combination comprising an inhibitor of CDK2 and/or CDK7 and/or CDK9, or a pharmaceutically acceptable salt thereof, and methylprednisolone, and its use in the treatment of diseases associated with antinuclear antibodies, such as SLE. | 12-06-2012 |